L. Esparcia-Pinedo

Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination

F. Sánchez‐Madrid, A. Alfranca, D. Real de Asúa, 2022, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

CD4+ T Cell Immune Specificity Changes After Vaccination in Healthy And COVID-19 Convalescent Subjects

F. Sánchez‐Madrid, A. Alfranca, C. Muñoz‐Calleja, 2022, Frontiers in Immunology.

The age again in the eye of the COVID-19 storm: evidence-based decision making

R. Rojo, D. San Segundo, M. López-Hoyos, 2021, Immunity & ageing : I & A.

Analysis of humoral and cellular immunity after SARS-CoV-2 vaccination in patients with multiple sclerosis treated with immunomodulatory drugs

F. Sánchez‐Madrid, A. Alfranca, V. Meca-Lallana, 2023, Clinical Immunology Communications.

Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination

F. Sánchez‐Madrid, A. Alfranca, D. Real de Asúa, 2022, medRxiv.

Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer

A. Alfranca, N. Romero-Laorden, L. Esparcia-Pinedo, 2023, Frontiers in immunology.